SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $100K invested in Sonnet BioTherapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$22K

Top Sellers

1
-$14K
2
-$11K
3
-$8K
4
Bank of America
Bank of America
North Carolina
-$4K
5
QCIG
Quad-Cities Investment Group
Iowa
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$34K
2
$22K
3
$14K
4
$12K
5
$7K
6
$6K
7
$3K
8
$2K
9
–
10
–